Autonomic dysfunction and progression of Parkinson's disease

Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae

Volumn 81, Issue 4, 2008, Pages 239-248

  Pospisil P ^a   Konecny L ^a   Pohanka, M ^a   Srovnalova H ^a   Rektorovaa I ^a   Siegelova J ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Autonomic dysfunction; Heart rate variability; Hoehn Yahr score; Metronome controlled breathing; Parkinson's disease; Rehabilitation; UPDRS

Indexed keywords

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HEART RATE VARIABILITY; HUMAN; PARKINSON DISEASE; POWER SPECTRUM; SPECTROSCOPY;

EID: 64949136535     PISSN: 12113395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Amino T et al. Profound cardiac sympathetic denervation occurs in Parkinson's disease. Brain Pathology 2005; 15(1): 29-34.
2. Bhattacharya KF et al. Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension. Parkinsonism and Related Disorders 2003; 9: 221-224.
3. Bouhaddi M et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy. Autonomic Neuroscience - Basic and Clinical 2004; 116 (1-2): 30-38.
4. Byung OC et al. Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease. Yonsei Med J 1998; 39 (5): 439-445.
5. Deiseroth T, Greulich W, Gehlen W. Changes of heart rate variability in the assessment of autonomic dysfunction in Parkinson's disease. EEG Clin Neurophysiology 1997; 102 (4): P41.
6. Devos D et al. Heart rate variability and Parkinson's disease severity. J Neural Transmission 2003; 110: 997-1011.
7. Djaldetti R, Melamed E, Gadoth N. Abnormal skin wrinkling in the less affected side in hemiparkinsonism - a possible test for sympathetic dysfunction in Parkinson's disease. Biomedicine and Pharmacotherapy 2001; 55 (8): 475-478.
8. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Archives of Neurology 1999; 56(1): 33-39.
9. Goldstein GS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurology 2003; 2: 669-676.
10. Gurevich TY et al. R-R interval variation in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2004; 109: 276-279.
11. Haapaniemi TH et al. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70: 305-310.
12. Haapaniemi TH et al. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. J Neurol 2000; 247 (11): 868-874.
13. Haas BM, Trew M, Castle PC. Effects of respiratory muscle weakness on daily living function, quality of life, activity levels and exercise capacity in mild to moderate Parkinson's disease. Amer J Physiol Med Rehabilitation 2004; 83 (8): 601-607.
14. Harnod T et al. Acute effects of bilateral subthalamic stimulator implantation on heart rate variability of patients with Parkinson's disease. Tzu Chi Med J 2005; 17 (1): 21-26.
15. Hartikainen JEK, Tahvanainen KUO, Kuusela TA. Short-term measurement of heart rate variability. In: Malik M, ed. Clinical guide to cardiac autonomic tests. Kluwer Academic Publishers, 1998: 149-176.
16. Havránková P, Roth J. Současná terapie Parkinsonovy choroby [Current therapy of Parkinson's disease]. Med Tribune 2006; 2/3: 6.
17. Hisayoshi O et al. Cardiovascular dysautonomia in de novo Parkinson's disease. J Neurol Sciences 2006; 241: 59-65.
18. Hsieh CW et al. Respiratory effect on the pulse spectrum. J Med Engineering Technology 2003; 27 (2): 77-84.
19. Chaudburi KR. Autonomic dysfunction in movement disorders. Curr Opinion Neurology 2001; 14 (4): 505-511.
20. Kallio M et al. Comparison of simple pulse rate change, power spectral analysis and fractal dimension as indicators of autonomic dysfunction in Parkinson's disease. EEG Clin Neurophysiology 1997; 103 (1): 184-185.
21. Kaufmann H et al. Autonomic failure as the initial presentation of Parkinsonism and dementia with Lewy bodies. Neurology 2004; 63 (6): 1093-1095.
22. Korchounov A, Kessler KR, Schipper HI. Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson's disease. Acta Neurol Scand 2004; 109 (1): 45-51.
23. Krygowska-Wajs et al. Autonomic nervous system dysfunction in Parkinson's disease evaluated by the heart rhythm variability test. Folia Med Cracov 1997; 38 (3-4): 47-52.
24. Krygowska-Wajs et al. Early diagnosis of orthostatic hypotension in idiopathic Parkinson's disease. Folia Med Cracov 2002; 43 (1-2): 59-67.
25. Linden D, Diehl RR, Berlit P. Sympathetic cardiovascular dysfunction in long-standing idiopathic Parkinson's disease. Clin Autonom Research 1997; 7 (6): 311-314.
26. Lucetti C et al. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement. Parkinsonism and Related Disorders 2006; 12: 279-283.
27. Meco G et al. Heart rate variability in Parkinson's disease patients treated with tolcapone. Parkinsonism and Related Disorders 2000; 6 (4): 223-227.
28. Médigue C et al. Relation between pulse interval and respiratory sinus arrhythmia: a time and frequency domain analysis of the effects of atropine. Eur J Physiology 2001; 441: 650-655.
29. Micielli G et al. Autonomic dysfunction in Parkinson's disease. Neurology Science 2003; 24: 32-34.
30. Oka H et al. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2006; 113: 221-227.
31. Penttilä J et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: effects of various respiratory patterns. Clin Physiology 2001; 21 (3): 365-376.
32. Piha SJ et al. Autonomic dysfunction in recent onset and advanced Parkinson's disease. Clin Neurology Neurosurgery 1988; 90 (3): 221-226.
33. Pospíšil P et al. Variabilita srdeční frekvence u Parkinsonovy choroby s kardiovaskulárnim onemocněním [Heart rate variability in Parkinson's disease with cardiovascular disease]. In: Optimální působení tělesné zátěže a výžiyy [Optimal effect of body workload and nutrition]. Hradec Králové: Univerzita Hradec Krľové, Pedagogická fakulta, 2006: 162-165.
34. Pospíšil P et al. Změny variability srdeční frekvence u pacientů s Parkinsonovou nemocí vyvolané řízeným dýcháním. Sborník abstrakt [Changes in heart rate variability in patients with Parkinson's disease produced by controlled breathing. Book of Abstracts] Luhačovice, 2007 (1): 29.
35. Rodriguez M, Sabate M, Troncoso E. Time and frequency domain analysis for the assessment of heart autonomic control in Parkinson's disease. J Neur Transmission 1996; 103 (4): 447-454.
36. Siddiqui MF et al. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism and Related Disorders 2002; 8 (4): 277-284.
37. Singer C et al. Autonomic dysfunction in men with Parkinson's disease. Eur Neurology 1992; 32 (3): 134-140.
38. Stark R et al. Effects of paced respiration on heart period and heart period variability. Psychophysiology 2000; 37: 302-309.
39. Strauss-Blasche G et al. Relative timing of inspiration and expiration affects respiratory sinus arrhythmia. Clin Exper Pharmacology Physiology 2001; 27: 601-606.
40. Van Dijk JG et al. Autonomic nervous system dysfunction in Parkinson's disease: relation with age, medication, duration and severity. J Neurol Neurosurg Psychiatry 1993; 56: 1090-1095.
41. Visser M et al. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA AUT. Movement Disorders 2004; 19(11): 1306-1311.
42. Yasuma F, Hayano J. Respiratory sinus arrhythmia. Why does the heartbeat synchronize with respiratory rhythm? Chest 2004; 125 (2): 683-690.
43. Zakrzewska-Pniewska B, Jamrozik Z. Are electrophysiological autonomic tests useful in the assessment of dysautonomia in Parkinson's disease? Parkinsonism and Related Disorders 2003; 9: 179-183.